Myelodysplastic Syndrome Whole Blood
Whole blood from donors with confirmed myelodysplastic syndrome (MDS). Useful for cytogenetic risk stratification and hypomethylating agent research.
Myelodysplastic Syndrome Whole Blood for Research
Myelodysplastic syndrome (MDS) is a group of bone marrow disorders characterized by ineffective blood cell production and a risk of progression to acute myeloid leukemia. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed MDS diagnosis for hematologic oncology research.
Product Features
- Fresh whole blood from clinically diagnosed MDS donors
- Custom anticoagulants and collection tubes available
- Same-day collection and shipment
- Research Use Only (RUO)
De-identified Donor Data
- Physician-confirmed diagnosis, including cytogenetic risk category where available
- Demographics: age, sex assigned at birth, ethnicity
- Relevant medical and treatment history
Applications
- Cytogenetic and molecular risk stratification research
- Bone marrow dysplasia biomarker studies
- Gene expression and transcriptomic analysis
- Hypomethylating agent therapy response research
Compliance and Quality
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
MDS whole blood is available in standard and custom volumes. Email learnmore@sanguinebio.com for international orders or documentation requirements.
Whole Blood
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.